IL-4 inhibits superoxide production by human mononuclear phagocytes.
Open Access
- 15 January 1990
- journal article
- research article
- Published by Oxford University Press (OUP) in The Journal of Immunology
- Vol. 144 (2) , 625-630
- https://doi.org/10.4049/jimmunol.144.2.625
Abstract
The activation of mononuclear phagocytes (M phi) and their generation of oxidative products is influenced by various cytokines as well as by normal maturational changes. We examined the effects of IL-4 on superoxide (O2-) production (cytochrome c reduction) by cultured M phi and the modulation of these effects by IFN-gamma and IL-1. Incubation of IL-4 (200 U/ml) with M phi inhibited M phi PMA (100 ng/ml)-stimulated O2-. production by 23% at 24 h, 34% at 48 h, and 70 to 85% at 72 to 96 h. IL-4 similarly inhibited M phi O2-. production in response to zymosan. IL-4 did not affect M phi viability, adherence to microtiter plates, or ability to phagocytose boiled yeast. In comparison with M phi, neutrophil O2-. production was not inhibited after 4 to 20 h incubation with IL-4. When IL-4 was washed out as early as 1 h after the initiation of M phi culture, significant inhibition of O2-. production was observed 4 days later. Sequential addition of either IL-4 or IFN-gamma to cultures demonstrated reciprocal cytokine effects on M phi; IL-4 partially inhibited O2-. production by M phi previously treated with rIFN-gamma whereas rIFN-gamma partially augmented O2-. production by M phi previously treated with IL-4. Because IL-4 has been reported to inhibit IL-1 production, add-back experiments were performed; addition of IL-1 only partly reconstituted O2-. production in IL-4-treated cells. Further characterization showed that although M phi protein synthesis was enhanced by both rIFN-gamma and IL-4 treatment, acid phosphatase, a marker of maturation to the macrophage phenotype, was markedly increased at an earlier time point in IL-4-treated M phi, and correlated with a decline in O2-. production. The ability of IL-4 to suppress M phi O2-. production implicates IL-4 as an important regulator of this aspect of the inflammatory response.This publication has 23 references indexed in Scilit:
- Human recombinant interleukin 4 induces Fc epsilon R2/CD23 on normal human monocytes.The Journal of Experimental Medicine, 1988
- Interleukin 4 induces cultured monocytes/macrophages to form giant multinucleated cells.The Journal of Experimental Medicine, 1988
- Expression of high affinity receptors for murine interleukin 4 (BSF-1) on hemopoietic and nonhemopoietic cells.The Journal of Immunology, 1988
- B cell stimulatory factor-1 (interleukin 4) activates macrophages for increased tumoricidal activity and expression of Ia antigens.The Journal of Immunology, 1987
- Bacterial lipopolysaccharides prime macrophages for enhanced release of arachidonic acid metabolites.The Journal of Experimental Medicine, 1986
- REEVALUATION OF CYTOCHROME B AND FLAVIN ADENINE-DINUCLEOTIDE IN NEUTROPHILS FROM PATIENTS WITH CHRONIC GRANULOMATOUS-DISEASE AND DESCRIPTION OF A FAMILY WITH PROBABLE AUTOSOMAL RECESSIVE INHERITANCE OF CYTOCHROME-B DEFICIENCY1986
- Recombinant human gamma-interferon induces human monocyte polykaryon formation.Proceedings of the National Academy of Sciences, 1984
- Identification of interferon-gamma as the lymphokine that activates human macrophage oxidative metabolism and antimicrobial activity.The Journal of Experimental Medicine, 1983
- Hydrogen peroxide metabolism in human monocytes during differentiation in vitro.Journal of Clinical Investigation, 1981
- Rapid microassays for the measurement of superoxide and hydrogen peroxide production by macrophages in culture using an automatic enzyme immunoassay readerJournal of Immunological Methods, 1981